{"abstract": "A federal advisory panel recommended approval of a rheumatoid arthritis pill known as tofacitinib, but several members expressed concern about its safety.", "web_url": "https://www.nytimes.com/2012/05/10/health/panel-supports-arthritis-pill.html", "snippet": "A federal advisory panel recommended approval of a rheumatoid arthritis pill known as tofacitinib, but several members expressed concern about its safety.", "lead_paragraph": "A federal advisory panel recommended approval on Wednesday of a rheumatoid arthritis pill that could offer patients an alternative to the injectable medicines already on the market, but several members expressed concern about safety and urged the Food and Drug Administration to require rigorous follow-up studies.", "print_section": "B", "print_page": "3", "source": "The New York Times", "multimedia": [], "headline": {"main": "Arthritis Pill From Pfizer Wins Support of U.S. Panel", "kicker": null, "content_kicker": null, "print_headline": "Arthritis Pill From Pfizer Wins Support Of U.S. Panel", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Pfizer Inc", "rank": 1, "major": "N"}, {"name": "subject", "value": "Accidents and Safety", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Rheumatoid Arthritis", "rank": 4, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 5, "major": "N"}], "pub_date": "2012-05-09T21:37:20+0000", "document_type": "article", "news_desk": "Business", "section_name": "Health", "byline": {"original": "By Katie Thomas", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/d9334e74-0af9-510f-8a94-24c705fee20e", "word_count": 425, "uri": "nyt://article/d9334e74-0af9-510f-8a94-24c705fee20e"}